mTORC Inhibitor Study on Preclinical ILC Mouse Model

Explore all data

References

Nelson, W. J., & Nusse, R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303(5663), 1483–1487.

Klempner, S. J., Myers, A. P., & Cantley, L. C. (2013). What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway. Cancer Discovery, 3(12), 1345–1354.

Tenbaum, S. P., et al. (2012). β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nature Medicine, 18(6), 892–901.

Essers, M. A. G. (2005). Functional Interaction Between β-Catenin and FOXO in Oxidative Stress Signaling. Science, 308(5725), 1181–1184.

Deng, J., et al. (2002). β-catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell, 2(4), 323–334.

Lin, L., Hron, J. D., & Peng, S. L. (2004). Regulation of NF-κB, Th Activation, and Autoinflammation by the Forkhead Transcription Factor Foxo3a. Immunity, 21(2), 203–213.

Solanas, G., et al. (2008). E-cadherin controls β-catenin and NF-κB transcriptional activity in mesenchymal gene expression. Journal of Cell Science, 121(13), 2224–2234.

Vinyoles, M., et al. (2014). Multivesicular GSK3 Sequestration upon Wnt Signaling Is Controlled by p120-Catenin/Cadherin Interaction with LRP5/6. Molecular Cell, 53(3), 444–457.